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Background: Clostridium sordellii can cause severe infections in animals and humans, the latter associated with
trauma, toxic shock and often-fatal gynaecological infections. Strains can produce two large clostridial cytotoxins
(LCCs), TcsL and TcsH, related to those produced by Clostridium difficile, Clostridium novyi and Clostridium perfringens,
but the genetic basis of toxin production remains uncharacterised.
Results: Phylogenetic analysis of the genome sequences of 44 strains isolated from human and animal infections in
the UK, US and Australia placed the species into four clades. Although all strains originated from animal or clinical
disease, only 5 strains contained LCC genes: 4 strains contain tcsL alone and one strain contains tcsL and tcsH. Four
toxin-positive strains were found within one clade. Where present, tcsL and tcsH were localised in a pathogenicity
locus, similar to but distinct from that present in C. difficile. In contrast to C. difficile, where the LCCs are chromosomally
localised, the C. sordellii tcsL and tcsH genes are localised on plasmids. Our data suggest gain and loss of entire toxigenic
plasmids in addition to horizontal transfer of the pathogenicity locus. A high quality, annotated sequence of ATCC9714
reveals many putative virulence factors including neuraminidase, phospholipase C and the cholesterol-dependent
cytolysin sordellilysin that are highly conserved between all strains studied.
Conclusions: Genome analysis of C. sordellii reveals that the LCCs, the major virulence factors, are localised on plasmids.
Many strains do not contain the LCC genes; it is probable that in several of these cases the plasmid has been lost upon
laboratory subculture. Our data are consistent with LCCs being the primary virulence factors in the majority of
infections, but LCC-negative strains may precipitate certain categories of infection. A high quality genome sequence
reveals putative virulence factors whose role in virulence can be investigated.
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Clostridium sordellii is an anaerobic, Gram-positive,
spore-forming species of bacterium [1]. It is commonly
found in the soil, and can be found in the gut of ani-
mals, including humans [2]; it has also been identified
in the vaginal microbiota of a small percentage of
women [3]. Human C. sordellii infections are rare but
can cause a variety of serious diseases, including myo-
necrosis and toxic shock syndrome [4–6]. Infections* Correspondence: n.fairweather@imperial.ac.uk
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unless otherwise stated.are most often associated with traumatic injury, surgery,
intravenous drug use and gynaecological events (child-
birth, abortion and miscarriage). They generally occur in
otherwise healthy individuals but have a high mortality
rate; wound infections have a mortality rate of ~50 %,
while gynaecological infections are almost universally fatal
[3]. An association between C. sordellii and the abortion-
inducing drug combination mifepristone-misoprostol has
been noted; misoprostol may facilitate infection by sup-
pressing the activity of the innate immune system [7].
Early symptoms of infection are non-specific, but within
hours of presentation most patients develop hypotension
and tachycardia that rapidly progresses to multi-organtral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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gen, causing disease in farm animals including sheep,
horses and cattle [8, 9].
The bacteria can produce several toxins and virulence
factors, of which lethal toxin (TcsL) and haemorrhagic
toxin (TcsH) are considered the most potent [10]. TcsL
and TcsH are members of the Large Clostridial Cytotoxin
(LCC) family [11] and are closely related to C. difficile
toxins TcdB and TcdA respectively [12]. Correlation of
TcsL production and disease suggests that TcsL is required
for C. sordellii to induce toxic shock syndrome [10]; in-
deed, while the tcsL+/ tcsH
− strain ATCC9714 is rapidly le-
thal in a mouse model of infection, mutation of tcsL
results in a complete loss of virulence [13]. Additionally,
certain strains of C. sordellii lacking LCCs have been asso-
ciated with less severe infections in humans [14, 15].
Other putative virulence factors produced by C. sordel-
lii include neuraminidase (nanS), phospholipase C (PLC,
csp) and, notably, the cholesterol-dependent cytolysin
sordellilysin (sdl) [16]. An earlier study of a collection of
14 strains isolated from human cadaver tissues revealed
that only one strain encoded and produced TcsL, and
while all strains encoded the sdl gene, only five produced
the protein, suggesting that not all strains are able to ex-
press their sdl genes, at least under the conditions used
[16]. This variation in toxin production between strains
may well account for the variation in disease type and
severity associated with this species.
We have undertaken a genomic analysis of a collection
of C. sordellii strains derived mainly from cases of clin-
ical or veterinary disease. The majority of strains do not
encode tcsL or tcsH, but all strains encode the putative
virulence factors sordellilysin, phospholipase C and neur-
aminidase. Where tcsL or tcsH are present, they are
localised on a plasmid. A high quality draft genome se-
quence of strain ATCC9714 reveals numerous other
putative virulence factors and will allow future studies
on the pathogenesis of C. sordellii infection.
Results
C. sordellii strains divide into four clades
A collection of 44 strains of C. sordellii was assembled
from both clinical and veterinary cases of disease within
the UK, USA and Australia (Table 1). Genomic DNA
was extracted and sequenced and core gene sequences
compared and analysed, generating a phylogenetic tree
(Fig. 1). This shows the strains can be divided into 4 pri-
mary clades. Five strains appear to be outliers from our
selection, not belonging to any clade (indicated with an *
in Fig. 1), though it is possible that were more strains
to be added these would fall into new, distinct clades.
Interestingly, no clade is specific to any country-of-
origin, or is specifically associated with either clinical
or veterinary disease.The majority of C. sordellii strains do not encode the
Large Clostridial Cytotoxins TcsL and TcsH
When analysing the initial sequence assemblies we no-
ticed that few strains appeared to contain the genes en-
coding the LCCs TcsL and TcsH. Five strains contain the
tcsL gene (ATCC9714, JGS444, JGS445, JGS6382 and
JGS6364), and of these only JGS6382 also contains tcsH.
The four tcsL+/tcsH − strains are closely related, all found
in Clade 1 of our phylogenetic tree, and all contain identi-
cal 5’ fragments of the tcsH gene, as previously reported
for ATCC9714 [17]. No strain contains tcsH without tcsL.
PCR using primers specific for tcsL or tcsH confirmed the
presence of the toxin genes only in these genomes (data
not shown). Strains encoding tcsL, or tcsL and tcsH, are
indicated by pL or pLH, respectively in Fig. 1 (and see
below). Intriguingly, tcsL was absent from strain UMC164.
UMC164 is part of clade 1 and therefore closely related to
all four tcsL+/tcsH − strains, and a previous analysis in
2006 indicated that it, too, was tcsL+/tcsH − [16]. UMC164
appears therefore to have lost the tcsL gene upon culturing
in the laboratory.
The C. sordellii LCC genes are located on one of two
plasmids found in ATCC9714
After initial optical mapping of the ATCC9714 genome,
it was determined that considerably more sequence
remained unmapped than gaps were estimated to remain
in the chromosome, suggesting that some of this se-
quence was localized on extra-chromosomal elements. A
large contig of 103.8 kb of unmapped sequence was as-
sembled which could not be optically mapped to the
chromosome. PCR demonstrated the circular nature of
this element, which we named plasmid pCS1-1. pCS1-1
contains tcsL, the alternative sigma factor tcsR and the
presumed holin protein tcsE, present in a pathogenicity
locus (PaLoc) in the relative orientations described pre-
viously [17]. The PaLoc region of pCS1-1 and the sur-
rounding genes are shown in Fig. 2. pCS1-1 also encodes
several proteins likely required for plasmid replication: a
replication initiation protein (ATCC9714PCS11_00101),
the plasmid-partitioning proteins ParA (ATCC9714PCS11_
00021) and ParB (ATCC9714PCS11_00011), a putative
topoisomerase (ATCC9714PCS11_00271), a RecA recom-
binase (ATCC9714PCS11_00141), a resolvase (ATCC9714
PCS11_00561) and a helix-destabilising single-stranded
DNA-binding protein (ATCC9714PCS11_00391). pCS1-1
also encodes a Type IV Secretion-System DNA conju-
gation protein (ATCC9714PCS11_00311) and a Type IV
Secretion-System coupling DNA-binding domain protein
(ATCC9714PCS11_00351), which may aid or enable conju-
gative transfer of the plasmid. Also found is a secreted
collagen-binding protein (ATCC9714PCS11_00241), and a
second copy of sortase (one is present on the chromosome)
Table 1 C. sordellii strains used in this study
Strain Source Associated infection or pathology ENA Accession numbers
R32977 ARU (UK) Knee Replacement [CELC01000001-CELC01000028[
R32921 ARU (UK) Death During Pregnancy [CEKV01000001-CEKV01000024[
R32668 ARU (UK) Wound Infection [CEKY01000001-CEKY01000028[
R32462 ARU (UK) Endo-Cervical Discharge [CEMX01000001-CEMX01000022[
R31809 ARU (UK) Traumatic Knee Injury [CEKW01000001-CEKW01000031[
R30684 ARU (UK) Calf Abscess [CELE01000001-CELE01000028]
R29426 ARU (UK) Sudden Death [CEMY01000001-CEMY01000040]
R28058 ARU (UK) Crushed Hand [CEKZ01000001-CEKZ01000028]
R27882 ARU (UK) Knee Amputation [CELB01000001-CELB01000031]
R26833 ARU (UK) Blood Culture from Diabetic [CELG01000001-CELG01000030]
W2967 VLA (UK) Veterinary Isolate [CELJ01000001-CELJ01000026]
W10 VLA (UK) Veterinary Isolate [CELH01000001-CELH01000051]
W2922 VLA (UK) Veterinary Isolate [CELK01000001-CELK01000153]
W2945 VLA (UK) Veterinary Isolate [CELI01000001-CELI01000027]
W2946 VLA (UK) Veterinary Isolate [CENA01000001-CENA01000080]
W2948 VLA (UK) Veterinary Isolate [CELF01000001-CELF01000026]
W2975 VLA (UK) Veterinary Isolate [CEKX01000001-CEKX01000030]
W3025 VLA (UK) Veterinary Isolate [CELA01000001-CELA01000022]
W3026 VLA (UK) Veterinary Isolate [CELD01000001-CELD01000043]
JGS444 ISU (USA) Myonecrosis, Bovine [CDNJ01000001-CDNJ01000028]
JGS445 ISU (USA) Myonecrosis, Bovine [CDNU01000001-CDNU01000031]
JGS6382 ISU (USA) [14] Myonecrosis, Bovine [LN681234-LN681235]
JGS6956 ISU (USA) Veterinary Isolate [CDNN01000001-CDNN01000034]
JGS6961 ISU (USA) Veterinary Isolate [CDNI01000001-CDNI01000027]
ATCC9714 ATCC (USA) [1] Oedema [LN679998- LN680000]
DA108 UMich (USA) [15] Post-Partum Endometritis. [CDNR01000001-CDNR01000036]
SSCC33589 UWA (AUS) Blood Isolate [CDNV01000001-CDNV01000026]
SSCC42239 UWA (AUS) Blood Isolate [CDNH01000001-CDNH01000029]
SSCC26591 UWA (AUS) Blood Isolate [CDNX01000001-CDNX01000035]
SSCC37615 UWA (AUS) Blood Isolate [CDNO01000001-CDNO01000031]
SSCC18838 UWA (AUS) Blood Isolate [CDNK01000001-CDNK01000030]
SSCC18392 UWA (AUS) Blood Isolate [CDNE01000001-CDNE01000027]
SSCC35109 UWA (AUS) Blood Isolate [CDNF01000001-CDNF01000036]
SSCC33587 UWA (AUS) Blood Isolate [CDNW01000001-CDNW01000028]
SSCC32135 UWA (AUS) Blood Isolate [CDNQ01000001-CDNQ01000031]
UMC1 OU (USA) [16] Allograft Isolate [CDNM01000001-CDNM01000035]
UMC2 OU (USA) [16] Allograft Isolate [CDLK01000001-CDLK01000054; LN681233]
UMC164 OU (USA) [16] Allograft Isolate [CDPO01000001-CDPO01000024]
UMC178 OU (USA) [16] Allograft Isolate [CDNP01000001-CDNP01000032]
UMC4401 OU (USA) [16] Allograft Isolate [CDNS01000001-CDNS01000027]
UMC4404 OU (USA) [16] Allograft Isolate [CDNY01000001-CDNY01000030]
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Table 1 C. sordellii strains used in this study (Continued)
E204 MU (AUS) Clinical Isolate [CDNL01000001-CDNL01000025]
R15892 ARU (UK) Clinical Isolate [CEKU01000001-CEKU01000032]
JGS6364 ISU (USA) Myonecrosis, Bovine [CDLJ01000001-CDLJ01000026; LN681232]
Strains were sourced as indicated: ARU, Anaerobe Reference Unit, Cardiff, UK; VLA, Veterinary Laboratories Agency, Weybridge, UK; ISU, Iowa State University,
Ames, IA, USA; ATCC, American Type Culture Collection, Manassas, VA, USA; UMich, University of Michigan, Ann Arbor, MI, USA; UWA, University of Western
Australia, Crawley, WA, Australia; OU, University of Oklahoma, Oklahoma City, OK, USA; MU, Monash University, Melbourne, VIC, Australia. The associated pathology
or infection is given where known and is human unless otherwise stated.
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teins to the cell wall.
An equivalent plasmid termed pCS1-3 was found in
JGS6382, the only strain in our collection that carries
tcsH. After assembly of pCS1-3 by PCR, we found that
the genes tcsL, tcsH and tcsE are arranged identically to
those in the tcsL+/tcsH+ strain VPI9048 (Fig. 2) [17].
Thus the tcsL and tcsE genes are in the same orientation,
but tcsH and tcsR are encoded on the opposite strand.
This orientation of the PaLoc genes is different to that
found in C. difficile where the homologous PaLoc genesFig. 1 Maximum likelihood phylogeny of 44 strains of C. sordellii of clinical
denotes nucleotide changes per position. 1000 bootstrap replicates were ru
nodes. Phylogenetic relationship between C. difficile MLST genes and their
strains not in a clade; pL, strains carrying tcsL on pCS1-1 or pCS1-2; pLH, s
similar plasmid lacking the PaLoc. Encircled numbers indicate hypothesisedtcdR, tcdB, tcdE and tcdA are in the same orientation.
No homologue of tcdC, a negative regulator of toxin ex-
pression in C. difficile [18] was found in any of the C.
sordellii isolates in our study. Though pCS1-3 is a simi-
lar size to pCS1-1 (106 kb) and contains a similar num-
ber of ORFs (94 compared to 90 on pCS1-1) it contains
several differences in addition to the presence of full-
length tcsH within the PaLoc. 29 ORFs are absent from
pCS1-3 relative to pCS1-1, including 2 universal stress
proteins and all genes encoding anaerobic sulphite re-
ductase subunits. However, 32 ORFs are present onand veterinary origin from the UK, USA and Australia. Scale bar
n resulting in bootstrap support values of greater than 89 % for all
C. sordellii homologues was used to establish the root. *, outlying
train carrying tcsL and tcsH on pCS1-3; p, strains carrying pCS1-4 or
points of entry of pCS1 type plasmids (see discussion)
Fig. 2 pCS1-type plasmids found in C. sordellii strains. PCR was used to confirm the circular nature of these plasmids. Only the regions encompassing
the PaLoc and the surrounding region are shown. ORFs are coloured according to function. The fragments of tcsH present in pCS1-1/pCS1-2 do not
encode any functional toxin component. Plasmids present in strains JGS444 and JGS445 were not assembled but are likely to be highly similar
to pCS1-1 (data not shown)
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itional copy of a resolvase and three transposase genes.
Analysis of the sequence of C. sordellii VPI9048 [17] re-
veals that most ORFs from pCS1-3 are also present, sug-
gesting that VPI9048, and potentially other tcsH +
strains, contain a highly related plasmid.
Visual examination of the genomes of the tcsL+/tcsH −
strains JGS444 and JGS445 suggests that they each carry
plasmids highly similar to pCS1-1, though these plas-
mids were not fully assembled by PCR. Examination of
the genome of the tcsL+/tcsH− strain JGS6364 showed
the presence of a plasmid similar to pCS1-1; however,
pulsed field gel electrophoresis showed the plasmid in
JGS6364 to be noticeably larger than pCS1-1 (Fig. 3),
which prompted us to assemble the plasmid by PCR toFig. 3 Southern hybridisation analysis of pulsed-field gels to confirm the pres
pulsed-field gel using C. sordellii genomic DNA-containing agarose plugs dige
specific probe; (B) the blot from panel A was stripped and reprobed with a p
using purified uncut C. sordellii genomic DNA, hybridised with a probe specifi
markers is indicated on the left, and the C. sordellii isolate corresponding to eaexamine the differences between it and pCS1-1. We desig-
nated the plasmid present in JGS6364 as pCS1-2 which, at
117.3 kb, is 13.5 kb larger than pCS1-1. The arrangement
of genes within the PaLoc of pCS1-2 was identical to in
pCS1-1 (Fig. 2), but several major differences were seen
elsewhere on the plasmid. Several genes are lost relative to
pCS1-1, including ones encoding a transcriptional regula-
tor and a cold shock protein. Several genes are present
which are not found on pCS1-1, including 23 found on a
21 kb insertion. These include various putative lantibiotic
biosynthesis genes and a putative lantibiotic-binding com-
ponent of an ABC transporter. It would be of interest to
determine if JGS6364 does indeed produce a lantibiotic,
because as far as we are aware lantibiotic synthesis has
not previously been identified in the Clostridia.ence of pCS1- and pCS2-type plasmids in C. sordellii strains. (A) A blot of a
sted with BlpI (to linearise pCS1-type plasmids), hybridised with a tcsL
robe specific for parB from pCS1-1; (C) a blot of a separate pulsed-field gel
c for ATCC9714PCS2_00141 from pCS2. The migration of molecular size
ch lane is indicated above
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(UMC2 and W10, indicated with a p in Fig. 1) were also
found to carry plasmids similar to pCS1-1. The 100 kb
plasmid in strain UMC2 was assembled by PCR and des-
ignated pCS1-4. pCS1-4 is highly similar to the pCS1
plasmids (Fig. 2), however the PaLoc genes are absent
and in their place a series of genes is present including a
transposase. Interestingly, in pCS1-3 and pCS1-4, up-
stream of a conserved putative MazE family antitoxin
gene a second transposase gene is found.
During manual assembly of the ATCC9714 genome a
second circular element, pCS2, was also identified. pCS2
(37.1 kb) is smaller than pCS1-1 and its relatives, and
contains 52 ORFs. pCS2 is clearly phage-derived, with
20 of its 52 ORFs annotated as phage genes, including
multiple genes encoding structural phage components. It
also contains two genes potentially involved in replication
(soj/parA (ATCC9714PCS2_00031) and a replication initi-
ator protein (ATCC9714PCS2_00011)). Whether this
element represents a phage or plasmid is unknown.
Confirmation of plasmid presence by PFGE and Southern
blot analysis
Southern hybridisation analysis of pulsed-field gels was
performed to confirm the presence of pCS1-type plas-
mids among C. sordellii isolates (Fig. 3). Examination of
the genome sequences of the five toxigenic C. sordellii
isolates and UMC2 indicated the presence of only a sin-
gle BlpI restriction site on all pCS1-type plasmids. To
linearise and therefore better visualise the pCS1-type
plasmids, C. sordellii genomic DNA-containing plugs were
digested with BlpI before being subjected to pulsed-field
gel analysis. All hybridisation bands observed for BlpI
digested samples in both the tcsL and parB blots (Fig. 3)
were also seen in the uncut samples (data not shown),
confirming that the bands shown in Fig. 3 represent line-
arised versions of the pCS1-type plasmids. In the tcsL blot,
a band corresponding to the size of the pCS1-1 plasmid
(103 kb) can be seen (Fig. 3A). Bands of equal or higher
molecular weight are evident from other toxigenic C. sor-
dellii isolates, however, no bands were observed for the
non-toxigenic isolates R28058 and UMC2. The size of the
pCS1-type plasmids in JGS444 and JGS445 appears to be
equal to that of the plasmid in ATCC9714, supporting
genome sequence data that indicates these strains carry
plasmids highly similar to pCS1-1. The band correspond-
ing to pCS1-3 in JGS6382 appears to be of slightly higher
molecular weight than that of pCS1-1, which agrees
with the size of pCS1-3 (106 kb) based on genome se-
quence analysis. The band corresponding to pCS1-2
from JGS6364 is of higher molecular weight than all
other pCS1-type plasmids, as discussed earlier. An
identical hybridisation pattern can be seen for the parB
blot in comparison to the tcsL blot for the toxigenic C.sordellii isolates and the negative control R28058, how-
ever, a band can also be seen in the parB blot for
UMC2 (Fig. 3B), confirming the presence of plasmid
pCS1-4 in this strain. A probe for a locus on the pCS2
plasmid (ATCC9714PCS2_00141) was used to confirm
the presence of this plasmid in ATCC9714 and to de-
termine if it is present in the other C. sordellii isolates
tested. A band can be seen in uncut ATCC9714 gen-
omic DNA in the pCS2 blot, indicating that this
plasmid is present in this strain (Fig. 3C). Similar bands
can be observed from both JGS444 and JGS445, indi-
cating that pCS2 or a related plasmid is also present in
these strains, which may be expected as these isolates
are phylogenetically related to ATCC9714 (Fig. 1). Indeed,
visual analysis of all 44 genome sequences suggests
pCS2 is also found in the closely related clade 1 strains
UMC164 and R15892. The pCS2 probe did not hybrid-
ise to the genomic DNA from any of the remaining C.
sordellii isolates in the panel of strains tested indicating
that this plasmid is not present among these strains.
The ATCC9714 genome
The sequence of strain ATCC9714 was refined, produ-
cing a high quality reference genome. 3282 ORFs are
annotated on the chromosome, together with 90 on
pCS1-1 and 52 on pCS2 giving a total of 3424. This is in
line with other Clostridial species – significantly more
than C. perfringens or C. tetani (strains 13 and E88 re-
spectively have approximately 2660 and 2580 chromo-
somal ORFs) but fewer than C. difficile strain 630, which
has approximately 3680. ATCC9714 contains the fewest
ORFs of the strains in our collection, the most being 3957
ORFs in strain UMC2, and the average being 3459 ORFs.
However, these figures are preliminary, as the genomes
other than ATCC9714 have undergone little improvement
to reduce contig number, which would almost certainly
reduce the number of ORFs identified. Further analysis
would also allow the identification and assembly of
plasmids.
Putative virulence factors
168 putative secreted proteins were identified in the
ATCC9714 genome (Additional file 1), six of which are
encoded by pCS1-1 and one by pCS2. Of the 168 ORFs, 66
are predicted to encode lipoproteins, including one encoded
on pCS1 and a second on pCS2. There are also nine pre-
dicted cell wall proteins, which contain 3 adjacent S-layer
homology (SLH) domains, which can non-covalently attach
proteins to the cell wall [19]. This attachment requires pyr-
uvylation of the cell wall by the protein CsaB [19], which is
encoded on the chromosome (ATCC9714_28031). The
csaB gene is located just downstream of two SLH domain-
containing genes, ATCC9714_28071 (function unknown)
and ATCC9714_28081 (a putative amidase). Based on their
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Bacillus anthracis [19], these SLH-domain proteins might
be constituents of an S-layer.
Four probable exotoxins were identified: a secreted colla-
genase colA (ATCC9714_10061), the cholesterol-dependent
cytolysin (CDC) sdl (sordellilysin) (ATCC9714_18311), the
neuraminidase nanS (ATCC9714_16161) and phospholip-
ase C (csp, ATCC9714_31321). The sdl gene is highly con-
served between all strains sequenced (≥97 % protein
sequence identity). The encoded protein shows strong
similarity to perfringolysin O from C. perfringens, and all
residues identified as being of functional or structural im-
portance in perfringolysin O [20, 21] are conserved in sor-
dellilysin, including the undecapeptide. It has previously
been shown that sordellilysin functions as a CDC, but that
not all strains containing the sdl gene produce SDL under
standard conditions. Such strains include ATCC9714,
UMC164 and UMC178, all part of this collection [16].
NanS is a homologue of the small C. perfringens neur-
aminidase NanH [22]. Multiple catalytically and structur-
ally important residues and motifs have been identified,
including four structurally important ‘Asp-Boxes’, all of
which are conserved in the ATCC9714 NanS. One import-
ant difference between C. sordellii NanS and C. perfringens
NanH is that NanH is located in the cytoplasm, while
NanS possesses a signal sequence and has been shown to
be secreted, and indeed to cause/contribute to the leuke-
moid reaction characteristic of severe C. sordellii infection
[23]. NanS is extremely well conserved between all 44
strains in our collection (≥97 % protein sequence identity);
however, two strains, the closely related SSCC37615 and
SSCC18838 from clade 2, possess a G= > A point mutation
resulting in a Asp162Asn mutation. Asp162 is the equiva-
lent of NanH Asp144, which has been shown to be neces-
sary for correct folding of the protein [22]. NanS produced
by these strains may therefore not be fully functional.
Csp is closely related to several Clostridial phospholi-
pases C, including the Clostridium bifermentans phospho-
lipase C and C. perfringens α-toxin. C. sordellii ATCC9714
Csp has been shown to be enzymatically active, but less
active than α-toxin, less haemolytic and, alone, to be non-
toxic to mice [24]. All known residues essential for enzym-
atic activity and structural maintenance are conserved
within the C. sordellii protein [24]. Strains have previously
been identified which do not produce Csp, although the
majority do [16]. Four closely related strains from clade 4
(R26833, R29426, SSCC35109 and R31809) all possess a
T= >A point mutation in codon 50, resulting in the for-
mation of a premature stop codon, which will preventing
production of Csp. JGS6382 has an N-terminal truncation
resulting in the absence of a signal sequence, meaning it
may produce Csp but will not secrete it. All other strains
are predicted to produce functional Csp, though JGS6956
Csp has a slight C-terminal truncation. The C-terminus ofα-toxin is believed to bind Ca2+ ions [25]; the truncation
found in JGS6956 Csp would likely render it unable to
bind Ca2+, which may affect its function.
We are unaware of any prior studies on ColA, the C.
sordellii collagenase. Comparison with ColG from C. his-
tolyticum, the only Clostridial collagenase for which a
structure is available, shows some similarity (33 % se-
quence identity) and the conservation of several import-
ant residues, including all those which bind the catalytic
Zn2+ ion and others important in substrate recognition.
However, mature ColA is 79 amino acids shorter than
ColG, and the PKD-like domain, important in ColG sub-
strate binding [26], is entirely absent from ColA, raising
questions as to how it binds its substrate. However, ColA
is well conserved between all strains of C. sordellii in
our collection (≥95 % sequence identity).
Two putative virulence factors were identified which
have predicted functions in immune evasion. ATCC9714_
13801 encodes aureolysin, a secreted metalloprotease
first identified in Staphylococcus aureus which cleaves
complement protein C3, preventing complement acti-
vation during infection [27], and the anti-microbial
peptide LL-37 [28], aiding evasion of the host immune
system during infection. ATCC9714_09801 contains a
Mac-1 domain, which is found in the Streptococcus pyo-
genes protein IdeS and contains a protease function
which specifically cleaves human IgG, aiding immune
evasion [29].
Two putative adhesins were also identified on the
chromosome. The first is a secreted collagen-binding
protein of >140 kDa (ATCC9714_22821/22831), contain-
ing at least 7 CnaB repeats. Due to the length and repeti-
tive nature of this gene we were unable to fully sequence
it, so it is split across two contigs. The second adhesin is
encoded by another large gene (ATCC9714_14191) which
contains two discoidin domains; in eukaryotes discoidin
domain receptors (DDRs) bind collagen [30]. ATCC9714
also contains two Type IV Pili (T4P) gene clusters
(ATCC9714_01091-ATCC9714_01201 and ATCC9714_
02121-ATCC9714_02151). T4P are able to promote adhe-
sion both between bacterial cells in biofilms and between
bacterial and mammalian cells, and thus commonly act at
as virulence factors [31]. These putative adhesins and T4P
clusters are conserved in every strain sequenced, as are
genes encoding a full flagella apparatus.
It has previously been shown that many, but not all,
strains of C. sordellii possess urease activity [32, 33].
Urease is a nickel-containing metalloenzyme that hy-
drolyses urea into ammonia and carbonic acid. It acts as
a virulence factor in several bacterial and fungal patho-
gens, including Helicobacter pylori and Klebsiella species
[34], though there is no evidence that urease acts as a
virulence factor in C. sordellii. We found complete urease
operons in all strains in our collection except SSCC26591.
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cated on the chromosome immediately upstream of nanS
(ATCC9714_16171 – 16241). To our knowledge no other
Clostridia carry chromosomal urease genes, though a
small minority of strains of C. perfringens are known to
carry urease genes borne on a plasmid [35]. The urease
enzyme itself comprises UreABC proteins that initially
form an apoenzyme that is activated by the UreDFG com-
plex. UreE is a Ni-binding chaperone and UreI is a urea
transporter. All genes are highly conserved between
strains (≥87 % protein sequence conservation from every
gene). UreC contains the enzyme’s active site and all previ-
ously identified Ni-binding/catalytically active residues are
conserved across all UreCs encoded in our collection [36].
Sporulation and germination
All clostridial species are able to form metabolically in-
active, stress-resistant spores [37]. Sporulation is con-
trolled by the master regulator spo0A, a transcriptional
regulator which controls expression of sporulation genes
[38]. As expected, spo0A is present in C. sordellii
ATCC9714 (ATCC9714_26501). In Bacillus subtilis the
proteins Spo0F and Spo0B form a phosphorelay from
the kinase KinA, resulting in downstream Spo0A phos-
phorylation and activation [38]. C. difficile lacks the
spo0F and spo0B genes, and Spo0A is instead directly
phosphorylated by two histidine kinases: CD630_1579
and CD630_2492 [39]. Two homologues of CD630_1579
have been identified in ATCC9714: ATCC9714_07111
and ATCC9714_16961, suggesting a similar mode of
regulation and activation of Spo0A in C. sordellii as in
C. difficile.
The majority of the sporulation machinery appears to
be conserved between C. difficile and C. sordellii, and it
is likely that the sporulation process in C. sordellii is
similar to that in C. difficile. Also highly similar to C.
difficile are the spore-coat proteins found in C. sordellii. 8
proteins have been confirmed as constituents of the
spore-coat in C. difficile strain 630: CotABDEFG, CotCB
and SodA [40]. Likely homologues have been identified in
C. sordellii ATCC9714 of CotA (ATCC9714_1722), CotB
(ATCC9714_05091), CotD (ATCC9714_05851), CotE
(ATCC9714_12131), and SodA (ATCC9714_20791). No
specific homologues have been identified for CotCB,
CotF or CotG; however, CotCB and CotG are highly
similar to CotD and are both also closely homologous to
ATCC9714_05851. CotF is homologous to ATCC9714_
05861, though this gene appears more closely related
to the C. difficile gene CD630_2400, currently anno-
tated as the putative spore-coat gene, cotJB2, which is
very similar to cotF but is not yet uncharacterised. It
thus seems likely that the C. sordellii spore-coat is
similar to that of C. difficile, but potentially simpler;
where C. difficile possesses 2 or 3 paralogues of certaingenes (cotCB, cotD and cotG, or cotF and cotJB2), C. sor-
dellii possesses only one equivalent gene. One potentially
significant difference between C. difficile and C. sordellii
spores has been identified. C. difficile 630 has three bclA
genes, homologues of which in B. anthracis encode glyco-
proteins forming filaments on the surface of the spore
[41]. No such homologues were identified in C. sordellii
ATCC9714.
Spores are able to germinate and produce vegetative
cells. Germination of both C. difficile and C. sordellii
spores is known to be initiated by spore surface recep-
tors that recognise and bind mammalian bile salts [42].
The only known bile salt receptor in C. difficile is the
serine protease CspC [43], a homologue of which is also
found in C. sordellii ATCC9714 (ATCC9714_11661).
Discussion
Our genomic analysis of a collection of C. sordellii
strains reveals several important findings related to the
phylogeny of the species and to the pathogenesis of dis-
ease. Phylogenetic analysis reveals the presence of four
clades within our strain collection, which includes
strains from diverse geographical locations and from in-
fections of both veterinary and medical origin. None of
the four assigned clades is specifically associated with ei-
ther clinical or veterinary disease; rather, both clinical
and veterinary isolates are found in each, suggesting that
no group of strains has adapted to any specific host.
Also, no clade is specifically associated with any country
of origin. Given the relative geographical isolation of the
USA, UK and Australia, one might have expected strains
located in each nation to have diverged. The fact that
strains sourced from each country are closely related to
strains sourced from the others may suggest recent
transfer of strains between countries. How this has oc-
curred remains unclear, though one likely possibility is
through human activity such as travel or export of
livestock.
We found that only a small minority of C. sordellii
strains contain the LCC genes tcsL and tcsH. A similar
but smaller study in 2006 resulted in similar findings,
with only 1 of 14 isolates analysed containing tcsL and
none containing tcsH [16]. In our study, 5 out of 44
strains encode tcsL, though two of those (JGS444 &
JGS445) are highly related, suggesting they may in fact
be the same strain collected from different sources, pos-
sibly during a minor outbreak, and only one carries tcsH.
The 44 strains sequenced here provide a likely representa-
tion of the species as a whole, suggesting that only a mi-
nority of strains isolated carry tcsL and that tcsL+/tcsH+
strains are rare. In support of this, a recent study of 52 iso-
lates from a single US strain collection found only 3 to
contain tcsH (by PCR), although the number containing
tcsL was not reported [44].
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encoded. Strain UMC164 was previously shown to carry
tcsL, and indeed to produce the toxin [16], but the iso-
late we analysed lacks tcsL and the other PaLoc genes.
This suggests that the original isolate of UMC164 car-
ried a pCS1-type plasmid but this was lost during sub-
culturing. Indeed, in a recent paper describing clinical
cases of C. sordellii infection, Bouvet et al. [45] specu-
lated that the LCC genes are encoded on a mobile gen-
etic element which is lost upon sub-culture. They report
isolating strains of C. sordellii lacking the tcsL gene from
clinical cases where toxin activity had been demon-
strated in intestinal contents. It is therefore likely that
the majority of C. sordellii infections are due to strains
containing a PaLoc on pCS1-type plasmids, but that
these genetic elements are often lost from strains during
subculture. Thus the PaLoc and its associated plasmid
may be present in a considerably larger proportion of
naturally occurring C. sordellii strains than indicated by
previous studies and indeed our own genome survey.
The availability of the DNA sequences for the plasmid
and toxin genes will allow early analysis of clinical sam-
ples by PCR which could identify toxin genes before they
are lost upon subculture.
A previous study employed genetic inactivation of tcsL
in ATCC9714 to probe the requirement of TcsL to es-
tablish disease in two mouse models of infection [13]. In
both models the wild type strain caused severe disease
while the tcsL mutant was avirulent, demonstrating that
TcsL is an essential virulence factor in these models, and
other studies have also indicated that TcsL is required
for the establishment of toxic shock associated with se-
vere C. sordellii infections, though non-toxigenic strains
are capable of causing less severe infections [14, 15].
Given that the majority of strains in our collection are
from clinical/veterinary cases of disease, it seems likely
that a significant number of them might have originally
harboured a pCS1-type plasmid, which has been lost
upon laboratory subculture. This would include UMC164
(as stated above) and any which were associated with
severe infections/toxic shock syndrome. From our phylo-
genetic tree, strain R15892 has probably lost a pCS1-type
plasmid, being closely related to the tcsL+ strains
ATCC9714 and JGS444/445. It is a matter of specula-
tion why some strains lose their toxin-encoding plas-
mid while others don’t. Possibilities include the pCS-1
plasmids being stable variants of the highly unstable
plasmids or the unstable plasmids having a distinct rep-
lication or partition apparatus conferring instability
under laboratory conditions.
We should not assume that all strains lacking the
PaLoc were once toxigenic and have since lost their
pCS1-type plasmids. The ‘UMC’ strains were obtained
from cadavers and had not caused infection in their hosthumans [16], meaning some of them at least might be
avirulent. It is also possible that some of the strains de-
scribed here may have caused infections despite lacking
tcsL. It has been estimated that only two-thirds of re-
ported cases of C. sordellii infection are associated with
toxic shock syndrome, and this could even be an over-
estimate with less dramatic cases being overlooked [14].
At least one of the non-toxigenic strains, DA-108, was
derived from a clinical infection not associated with
toxic shock syndrome [15], while strain W10 was iso-
lated from a veterinary infection but appears to carry a
pCS1-4-like plasmid; i.e. it still carries a pCS1-type plas-
mid but lacks tcsL. All strains in our study contain other
putative virulence factors including the cholesterol-
dependent cytolysin sordellilysin (sdl), neuraminidase
(nanS), phospholipase C (csp) and collagenase (colA).
Cases of C. sordellii invasive disease not linked to toxic
shock syndrome and caused by apparently LCC-negative
strains have been described [14, 15, 46, 47]. It is there-
fore possible that a number of these strains were non-
toxigenic at the time of infection and were associated
with less severe disease (e.g. R30684 was isolated from
an abscess).
In C. difficile, the toxin genes tcdA and tcdB are chro-
mosomally localised and strains carrying both toxin
genes tcdA and tcdB constitute the majority of strains
isolated from C. difficile infections, with those carrying
only tcdB comprising around 5-10 % of clinical isolates
[48, 49]. Non-toxic C. difficile strains are routinely iso-
lated from patients [49], but it remains to be demon-
strated that such tcdA−/tcdB− strains are pathogenic.
Interestingly, to date no naturally occurring C. difficile
tcdA+/tcdB− strains or C. sordellii tcsH+/tcsL− strains
have been found. The relative orientations of the C. sor-
dellii toxin genes and their regulatory genes tcsE and
tcsR are distinct to those found in C. difficile, while no
homologue of tcdC, which negatively regulates toxin
production in C. difficile [18], is present.
Our findings raise the question of the evolution of the
LCC genes. Our phylogenetic analysis suggests that a
pCS1-like plasmid has entered strains of C. sordellii on
at least 3 occasions (see Fig. 1). One possible chronology
is as follows: pCS1-3, bearing both tcsL and tcsH, first
entered C. sordellii (indicated by “1” in Fig. 1). On a sec-
ond occasion, “2”, pCS1-3 entered into the ancestor
strain of clade 1, which includes ATCC9714. Herein a
rearrangement occurred resulting in the loss of the vast
majority of tcsH and the eventual formation of pCS1-1
and pCS1-2. On a third occasion, “3”, pCS1-3 could have
entered an ancestor of strains UMC2 and W10 and
undergone a rearrangement resulting in the loss of the
entire PaLoc, forming pCS1-4. Of course, several other
potential chronologies exist, and given the possibility that
multiple strains may have once carried such a plasmid and
Couchman et al. BMC Genomics  (2015) 16:392 Page 10 of 13since lost it this analysis may be lacking. Whole genome
sequencing of other known tcsL+ strains would allow im-
provement of this tree and greater understanding of the
distribution of these plasmids throughout the species.
Another question is the origin of the LCC genes in C.
sordellii, and whether the plasmid bearing them is
passed directly between strains of C. sordellii or is trans-
ferred via an external intermediate. It has recently been
shown that C. difficile LCC genes can undergo horizon-
tal transfer between strains, a process likely mediated via
conjugative transposons [50], but it is not yet known
whether the LCC genes of C. sordellii can be transferred
between strains via plasmid transfer.
Conclusion
Our sequencing of C. sordellii genomes reveals a sur-
prising deficit of LCC genes, that where present they are
plasmid-localised, and evidence of plasmid loss from
certain strains. This suggests that the LCC genes may be
more widespread within the species than the screening
of isolates initially indicates. Less severe infections may
be caused by LCC-negative strains where virulence is fa-
cilitated by other virulence factors, some of which we
identified in strain ATCC9714. Although a clade struc-
ture was identifiable in our collection of strains, these
did not divide by geographical region or by infected host
species. The high-quality reference genome sequence of C.
sordelllii ATCC9714 will enable further research on this
important pathogen. Finally, comparison of C. sordelllii se-
quences with those of other pathogenic clostridia will help
to characterise the wide range of strategies that the clos-
tridia use to survive and proliferate in man and animals.
Methods
Bacterial strains and growth conditions
C. sordellii strains were grown in BHIS broth (37 g/L
Brain-Heart Infusion, 5 g/L yeast extract, 1 g/L L-Cysteine)
or on BHIS agar (as above, with 15 g/L agar) in an anaer-
obic cabinet (Don Whitley Scientific) in an atmosphere of
80 % N2, 10 % CO2 and 10 % H. A full list of strains used
in this study can be found in Table 1.
DNA extraction and sequencing
Genomic DNA was prepared by growth of 25 ml over-
night cultures of C. sordellii in BHIS broth. Cells were har-
vested by centrifugation (4000 x g, 10 min). Cells were
frozen at -80 °C for 1 h then re-suspended in 400 μl lysis
buffer (200 mM NaCl, 50 mM EDTA, 20 mM Tris–HCl,
pH 8). Lysozyme (2 mg/ml) and RNase A (0.1 mg/ml)
were added and the suspension incubated at 37 °C for 2 h.
Proteinase K (0.5 mg/ml) and SDS (1 %) were added and
the suspension incubated at 50 °C for 1 h. DNA was
then extracted using phenol/chloroform, and precipitated
by adding 2.5 volumes of ice-cold ethanol followed byovernight incubation at -20 °C. DNA was harvested by
centrifugation at 17 900 x g for 5 min at 4 °C, washed with
1 ml 70 % ethanol, centrifuged at 17 900 x g for 5 min at
4 °C again and the supernatant removed. The pellet was
air-dried at room temperature then resuspended in H2O.
Genomic DNA was sequenced on an Illumina Hi-Seq in a
multiplex run of 48 samples.
Assembly of genomes and annotation
De novo assembly of the Illumina sequence data into
contigs was carried out using VelvetOptimiser (Victorian
Bioinformatics Consortium). The genome of ATCC9714
was then optically mapped [51] (see below), establishing
the order and relative orientations of all contigs >50 kb.
Gapfiller [52] (BaseClear) was then used to attempt to
computationally close sequence gaps and iCORN (http://
icorn.sourceforge.net) to correct for any sequence errors.
CDSs (Coding DNA Sequences) were identified using
Prodigal [53] and functional annotation was transferred
using four other clostridial genomes as references in an
iterative process: C. difficile 630 (accession number
AM180355); Clostridium botulinum Hall A (Proteolytic)
(accession number AM412317); C. botulinum E3 Strain Al-
aska E43 (non-proteolytic) (accession number CP001078);
Clostridium novyi NT (accession number CP000382) (in
that order). The genome sequence was further improved
using a combination of manual inspection of sequence
data, PCR and comparison to the other C. sordellii strains
and other clostridia. (For primer sequences, see Additional
file 2). Subsequent mapping of the sequence data to the
optical map allowed for validation of the genome assem-
bly. Annotation to identify coding sequences, assign pre-
dicted functions and to predict RNA structures of the
other C. sordellii strains was generated using Prokka [54].
Optical mapping
BglII was identified by OpGen enzyme selection software
as an appropriate restriction enzyme with which to di-
gest C. sordellii gDNA. 2 μl gDNA was applied to an
OpGen MapCard and run on an Argus® system follow-
ing manufacturer’s protocols. The MapCard chambers
were loaded with JOJO™ stain and OpGen enzyme, buf-
fer and antifade, and the card cycled on the Argus® MCP
(MapCard Processing Unit) for approximately 25 min at
37 °C. Following data collection, contig assembly was per-
formed using Argus® MapManager™; prior to assembly the
mapset was filtered for minimum molecule size >250 kb,
minimum fragments per molecule >12 and minimum
molecule quality >0.4. The genome was initially assembled
into a contiguous, circularized chromosome. Any regions
of low coverage were improved using the "Find Hits" fea-
ture until depth of coverage reached 30x. The QC module
was then used to perform a QC review to ensure all re-
gions of map assembly were robust. The de novo sequence
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Mapsolver. 89.8 % of the de novo sequence assembly was
aligned to the Optical Map with the remainder either con-
tigs smaller than 50 kb which were too small to accurately
align or plasmid sequence which was not incorporated
into the Optical Map assembly.Generation of phylogenetic tree
A core genome of C. sordellii was created using CD-HIT
[55] to perform an initial clustering of the common
genes shared between all 44 strains based on a 90 %
identity threshold followed by an all-against-all blast, the
results of which were then input to a Markov Cluster
Algorithm to perform the final clustering. In total 2712
genes were clustered to create the core C. sordellii gen-
ome. The sequences were concatenated and a nucleotide
alignment was created using Muscle [56]. A maximum
likelihood phylogeny was generated from the aligned se-
quence using FastTree version 2.1.3 [57] with the follow-
ing settings: a Generalised Time-Reversible (GTR) model
of nucleotide substitution and CAT approximation of the
variation in rates across sites with 20 rate categories.
BLASTN queries of the assembled C. sordellii genomes
along with reciprocal annotation using different mem-
bers of the order Clostridiales against the C. sordellii
ATCC9714 genome revealed C. difficile to be the clos-
est relative (86 % BLASTN identity). C. difficile proved
to be too diverse as an out-group to determine a
meaningful phylogeny with C. sordellii using the
methods described above. The root of the tree was
therefore established by aligning the 7 MLST genes
[58] of the C. difficile strain R20291 (Ribotype 027, Ac-
cession no. FN545816) with their corresponding C.
sordellii orthologues (all present in every strain at 90 %
identity) and generating a phylogeny from the align-
ment using FastTree as described above. R20291 was
chosen as it was the closest match to C. sordellii with a
high-quality sequence.PCR
PCR reactions were performed with KOD Hot Start
DNA polymerase (Merck Millipore). Reactions were set
up according to the manufacturer’s instructions. 200 ng
of gDNA was used in each reaction which entailed an
initial denaturation step (94 °C, 2 mins) followed by
30 cycles of: 94 °C, 15 s; primer Tm minus 5 °C, 30 s; 68 °C,
1 min/kb predicted product size. The primer Tms were
calculated using https://ecom.mwgdna.com/services/webgist/
mops.tcl. PCR products were purified using a Qiagen QIA-
quick® PCR Purification Kit. Screening for tcsL was per-
formed using primers NF2362 and NF2363 and for tcsH
using NF2351 and NF2352.Pulsed-field gel electrophoresis (PFGE)
Growth of C. sordellii for pulsed-field electrophoresis
analysis was conducted at 37 °C in an atmosphere of
10 % H2, 10 % CO2 and 80 % N2 in an anaerobic cham-
ber (Coy Laboratory Products, Inc). C. sordellii was
grown on Nutrient Agar (25 g/L Nutrient Broth No. 2
(Oxoid), 3 g/L yeast extract, 1 g/L sodium thioglycolate,
15 g/L agar, 0.375 % glucose) to obtain single colonies
prior to growth overnight in 20 mL BHI broth (35 g/L
Bacto Brain Heart Infusion (BD), 1 g/L sodium thiogly-
collate, 0.375 % glucose). Purified C. sordellii genomic
DNA was extracted from 5 mL of overnight BHI culture
as previously described [59] with the omission of RNAse
upon resuspension of DNA. To produce agarose plugs
containing C. sordellii genomic DNA, overnight BHI
cultures were used to inoculate fresh 20 ml BHI broths
to an OD600 of 0.1. These broth cultures were then
grown to an OD600 of ~1.0. The bacterial cells were pel-
leted from 10 ml of culture at 2466 x g for 8 min. Bac-
terial cells were washed in 10 ml PIV buffer (10 mM
Tris–HCl, 1 M NaCl, pH 7.6) and pelleted at 2466 x g
for 8 min. Cells were resuspended in 1 ml PIV buffer
and mixed with an equal volume of 1.5 % SeaPlaque®
Agarose (Lonza) in 0.5 x TBE buffer (the agarose having
been equilibrated to 50 °C). The cell-containing agarose
plugs were cast in 1.5 mm-thick moulds (Bio-Rad) at
room temperature (RT). The plugs were removed from
the moulds and incubated at 37 °C for 2 h with gentle
shaking in lysis buffer (0.5 M EDTA [pH 8], 0.5 % Sarko-
syl, 2.5 mg/ml lysozyme, 2 mg/ml deoxycholic acid). The
plugs were then incubated in proteinase K buffer (0.5 M
EDTA [pH 8], 0.5 % Sarkosyl, 1 mg/ml proteinase K) at
50 °C overnight. Plugs were then washed 4 x 15 min in
0.1 x TE, followed by washing in 1 x TE, all washing oc-
curring at RT with gentle shaking. Plugs were stored in
fresh 1 x TE at 4 °C. To linearise pCS1-type plasmids so
as to ensure more accurate size comparisons, agarose
plugs used in this experiment were incubated with or
without restriction enzyme BlpI (New England Biolabs)
in 450 μl NEBuffer 4 (New England Biolabs). PFGE of
both extracted genomic DNA and agarose gel plugs con-
taining genomic DNA were performed using a 1 %
Pulsed Field Certified Agarose (Bio-Rad) gel in 0.5 x
TBE buffer using the CHEF-DR III System (Bio-Rad) at
15 °C. A Mid-Range I PFG Marker (New England Bio-
labs) was used as a molecular size standard. Electrophor-
esis parameters were as follows: 6 V/cm, ramping pulse
from 1 to 25 s for 25 h. Gels were stained in GelRed
(Biotium) and photographed under UV light.
Southern Hybridisation
DNA from pulsed-field gels was transferred to a nylon
membrane (Roche) as previously described [60] with the
following modifications: 2 × 20 min incubations in
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tralisation solution and a 48 h transfer. The blots were
hybridised to a tcsL-specific PCR product amplified
using the primers DLP236 and DLP237, a pCS1 parB-
specific PCR product amplified using the primers
DLP377 and DLP378 or a ATCC9714PCS2_00141-spe-
cific PCR product amplified using the primers DLP362
and DLP363. All probes were amplified from C. sordellii
ATCC9714 genomic DNA. Probes were digoxigenin-
labelled using random PCR labelling according to the
manufacturer’s instructions (Roche). Hybridisation was
detected using the CDP-Star (Roche) chemilumines-
cence detection system according to the manufacturer’s
instructions.
Availability of supporting data
The sequences described here have been deposited in
the NCBI/EBI databases. Accession numbers for the
genome of each strain are given in Table 1. These are ac-
cessible through the WTSI website (http://www.sanger.
ac.uk/resources/downloads/bacteria).
Additional files
Additional file 1: Putative Secreted Proteins of C. sordellii strain
ATCC9714. Herein is contained a list of all putative secreted proteins
encoded by the genome of C. sordellii ATCC9714, as identified by SignalP
and Phobius, identifying them by gene number and indicating if they are
proposed to be lipoproteins, if they are annotated with a specific gene
product and giving a putative function based on BLAST analysis.
Additional file 2: Primers Used in This Study. Herein is contained a
list of all primers used in this study, giving their name/number, sequence
and what they were used for.
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